At the Atlas of the International Diabetes Federation in 2017, "Portugal represents one of the darkest places in Europe," said the endocrinologist Jácome de Castro. A situation that should be very present and be vigilant when indicated, November 14 World Diabetes Day.
For state endocrinologist diabetes it brings many other pathologies, so it's important to get the message that "off the kidney, eye and amputations, heart disease and heart death are one of the main enemies to be included in diabetes, because that's why patients die."
Cardiovascular risk is high in patients with diabetes, leading to cardiovascular diseases they are "responsible for more than 50% of mortality," the problem is all the more serious because in Portugal "diabetes is still a disease that is under control".
For Carlos Aguiar, cardiologist, "cardiovascular mortality is reduced, which shows the benefits of controlling risk factors," but despite this "there has been an increase in the incidence of obesity, which is the pathway for type 2 diabetes". This situation leads the cardiologist to say that what worries him "is that this increase in obesity and diabetes will cause death in cardiovascular causes."
"People tend to look at diabetes as a confectionery-eating problem, but here it's important that it's a life-threatening disease. When there's a cardiovascular disease, life expectancy is reduced by an average of eight to nine years If we have diabetes, the connection is really dangerous, which means that life is even shorter, "said the cardiologist.
The importance of the diagnosis
Diagnosis at an early stage to prevent complications associated with diabetes, including cardiovascular complications, is an increasing challenge for both medicine and patients. Jácome de Castro pointed out that in Portugal, the estimated data indicate that about 30% of patients with diabetes are undiagnosed. "It means that people are still alive, not knowing that they have a disease, and this time when they are exposed to high sugar values, they will destroy your body."
The term is a big challenge "in which there are very important clinical trials, the introduction of drugs with new mechanisms of action, new drugs acting at the kidney level, inflammation, wall vessels that affect the prognosis of cardiovascular diseases and that appear to protect the body" – said the endocrinologist.
Jácome de Castro stated: "Therefore, we must act before, we can not be satisfied with treating patients who seem complicated to us, we must be able to prevent these complications as much as possible." And in this aspect, the results of recent clinical trials put us in a very interesting at the diabetes clinic level in Portugal and around the world. "
Convert drugs to be compatible with therapy
"It is a pity that we have medicines that restore life, but the patient does not take them later," said Carlos Aguiar. Patient's attitude results from "drug compartmentalization", when the patient is told that the drug is taken to lower cholesterol, and when doing analysis, the values have already dropped, so it is reasonable to think which, if successful – actually lower cholesterol – then you can stop taking it. "
In the case of a cardiologist, drugs should be called by name, which means "they are aimed at extending the quantity and quality of life", which is why "it is almost compulsory to reclassify medicines".